Triple Negative Breast Cancer (TNBC) – Immunotherapy Trials
The research at Gynaekologisches Zentrum Bonn focuses on Triple Negative Breast Cancer, evaluating innovative neoadjuvant and adjuvant strategies to improve outcomes.
- Neoadjuvant immunotherapy combined with chemotherapy
- Assessment of pathological complete response (pCR)
- Long‑term event‑free survival monitoring
By integrating Pembrolizumab into treatment regimens, the site aims to increase cure rates and provide new therapeutic options for patients with this aggressive disease.
Contraceptive Research – Levonorgestrel Vaginal Delivery System
Studies conducted in the gynecology department investigate the Levonorgestrel Vaginal Delivery System to determine its effectiveness as a reliable birth control method.
- Hormonal contraceptive efficacy across multiple cycles
- Safety and tolerability in reproductive‑age women
- User acceptability and adherence to treatment schedule
The trial seeks to demonstrate robust contraceptive efficacy, offering an additional safe option for family planning at the Bonn center.
